Global Single-use Filtration Assemblies Market Size, Share & Industry Trends Analysis Report By Application, By Type (Membrane Filtration, Depth Filtration, Centrifugation and Others), By Membrane Filtration Type, By Product, By Regional Outlook and Fore

Global Single-use Filtration Assemblies Market Size, Share & Industry Trends Analysis Report By Application, By Type (Membrane Filtration, Depth Filtration, Centrifugation and Others), By Membrane Filtration Type, By Product, By Regional Outlook and Forecast, 2022 - 2028

The Global Single-use Filtration Assemblies Market size is expected to reach $8.1 billion by 2028, rising at a market growth of 17.8% CAGR during the forecast period.

Single-use components that guarantee a sterile fluid flow for pharmaceutical items are referred to as single-use assemblies. They are finished process systems with all-in-one, ready-to-use, customer-specific solutions made of different plastic pieces combined into one unit. Single-use assemblies provide the advantage of fewer concerns about cross-contamination and leakage, fewer production pauses, cheaper costs, and many other advantages.

In addition, the single-use filtration assemblies link the equipment and instruments used in laboratories and the medical field. Filtration assemblies, bottle assemblies, bag assemblies, and mixing system assemblies are the market's four primary categories of single-use assemblies. Filtration assemblies are utilized to vacuum filter various aqueous solutions, biological fluids, tissue culture medium, High-Performance Liquid Chromatography (HPLC), and other aqueous solutions.

Filtration assemblies include passing water through a porous medium to remove particle debris. Both generic and specialized solutions are available. Cell culture & mixing, storage, sampling, filtration, and fill-finish application are some of the several applications. Pharmaceutical and biopharmaceutical firms, academic and research institutions, and corporations performing contract research and production are some end users.

Since single-use filtration assemblies follow associated validation criteria and carry out sterilizing procedures, they eliminate the possibility of contamination compared to conventional stainless-steel systems. Each system is constructed according to welding application specifications using a reinforced hose.

COVID-19 Impact Analysis

The pandemic caused the suppliers to struggle to meet demand, which fueled the market expansion of single-use assembly. Because of the speed and flexibility needed, the platforms utilized to develop novel vaccines, like DNA, mRNA, and viral vectors, are typically built utilizing single-use technologies. Therefore, the pandemic may have affected market growth favorably because of the increasing demand for single-use assemblies. In addition, after the pandemic, the demand persisted due to the biopharmaceutical & pharmaceutical businesses that were the primary drivers of the market expansion's expansion using more single-use assemblies in developing and producing COVID-19 and other illnesses medicines. As a result, steady growth in the market is anticipated.

Market Growth Factors

Rapidly Evolving Biopharmaceutical Industry

The biopharmaceutical industry has grown faster than the pharmaceutical sector in recent years. This industry will continue to expand, according to analysts. Recent and anticipated steady increases in biopharmaceutical sales are attributable, among other things, to the growth of the elderly population and the resulting rise in the prevalence of chronic conditions, the rising number of diabetes and cancer patients, and the rising incidence of autoimmune diseases. Understanding the mechanisms behind diverse medical disorders has aided the identification of particular variables and processes that cause pathological alterations. This has motivated the continuation of research into the applicability of biopharmaceuticals to new therapeutic contexts.

Emerging trend of medical outsourcing

Healthcare businesses can utilize outsourcing as a way to reduce the rising expenses of providing services, which is becoming more increasingly pop. To provide high-quality healthcare facilities, healthcare organizations contract out a variety of services to multiple suppliers, including manufacturing or research. Medical record management, administrative costs, delivery costs, customer engagement, and clinical change are all reduced through healthcare outsourcing services for vendors. Furthermore, healthcare outsourcing lowers the cost of staff training and reduces billing errors. The market for single-use filtration assemblies is also predicted to grow as a result of the reduced cost.

Market Restraining Factors

Problems associated with leachables and extractables

The widespread demand to satisfy lower detection limits, which presents difficulties for equipment suppliers and laboratory scientists, is one of the main obstacles to leachables research. Modern mass spectrometry equipment and software are required to detect these low levels and analyze the data. Highly qualified and experienced analysts are required to design equipment methods or sample preparation techniques to satisfy these low analytical evaluation thresholds. In so-called dirty matrices like e-liquids, where natural flavors and biological samples can make it difficult to distinguish lower levels, prove to be important to formulation interference, the product formulation might affect sensitivity. Thus, the market expansion of single-use filtration assemblies is constrained by concerns about extractable and leachables.

Type Outlook

Based on type, the single-use filtration assemblies market is segmented into membrane filtration, depth filtration, centrifugation and others. The depth filtration segment covered a considerable revenue share in the single-use filtration assemblies market in 2021. This is because of its outstanding efficiency, low protein binding, and great dirt-holding capacity. In addition, a wide variety of impurities and contaminants can be effectively removed due to the depth filtration media, which is typically composed of various layers of particles or fibers in various sizes.

Application Outlook

On the basis of application, the single-use filtration assemblies market is divided into pharmaceuticals manufacturing market, bioprocessing/biopharmaceuticals market and laboratory use. In 2021, the bioprocessing/biopharmaceuticals market segment dominated the single-use filtration assemblies market with the maximum revenue share. Its expansion is attributable to the rising investment for research and development of biopharmaceutical goods. Single-use facilities are simpler to maintain in comparison to bioreactor systems.

Product Outlook

By product, the single-use filtration assemblies market is classified into filters, cartridges, membranes, manifold, cassettes, syringes and others. The filter segment registered the maximum revenue share in the single-use filtration assemblies market in 2021. Filters for one-time use are among the most common and frequently used single-use technologies. Using flocculating chemicals, filter aids, and protective profilers can improve the effectiveness of depth filters during clarity processes. Merck Millipore and Sartorius employ these procedures. In addition, the automation of filtration methods is anticipated to contribute to the growth of this segment.

Regional Outlook

Region-wise, the single-use filtration assemblies market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region led the single-use filtration assemblies market by generating the highest revenue share in 2021. The well-established public health system and rising demand for biopharmaceuticals in this region will further drive market expansion. In addition, several market leaders in North America have helped the market's expansion. Businesses are spending to fulfill the increased need for biotechnology solutions to enhance the manufacturing of vital components used to manufacture biologics, such as single-use technologies like bioreactor bags

The major strategies followed by the market participants are Product Launches, Acquisitions and Expansions. Based on the Analysis presented in the Cardinal matrix; Merck Millipore (Merck Group), 3M Company, Danaher Corporation, Thermo Fisher Scientific, Inc. is the forerunners in the Single-use Filtration Assemblies Market. Companies such as Sartorius AG and Repligen Corporation are some of the key innovators in Single-use Filtration Assemblies Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Sartorius AG, Repligen Corporation, Merck Millipore (Merck Group), Danaher Corporation, Thermo Fisher Scientific, Inc., Meissner Filtration Products, Inc., Cellab CDMO, Medela AG, and DrM, Dr. Mueller AG

Strategies Deployed in Single-use Filtration Assemblies Market

Product Launches and Product Expansions:

Sep-2022: Thermo Fisher Scientific, Inc. released Thermo Scientific™ DynaSpin™ Single-Use Centrifuge system, the new centrifuge technology. The product allows efficient cell culture harvesting and decreasing the usage of traditional depth filtration to build a faster, highly cost-efficient solution.

Sep-2022: Pall Corporation, a subsidiary of Danaher Corporation, expanded its bioprocessing solution with the addition of three new Allegro Connect Systems. The Allegro Connect Systems combine previously manual operations incuding filter integrity testing and single-use system leak testing, decreasing the demand for operator intervention. Also the Allegro systems suite consists of systems to support Virus Filtration and Bulk Fill, Depth Filtration and Buffer Management System to simplify the formation of manufacturing workflows.

Jun-2021: 3M Health Care Introduced 3M Harvest RC clarifier, a single-stage purification solution for the manufacturing of recombinant protein therapeutics. The product is designed as an efficient option to enhance monoclonal antibody (mAb) yields also organizing a traditionally multi-stage harvest clarification process into a single stage.

Acquisitions and Mergers:

Feb-2022: Sartorius Stedim Biotech, a subgroup of Sartorius, completed the acquisition of the chromatography division of Novasep, a leading supplier of services in the field of purification and molecule production. The acquisition of a chromatography suite consists of chromatography systems suitable for smaller biomolecules and advanced systems for the continuous production of biologics.

Sep-2021: Repligen Corporation took over Avitide, Inc, a company that discovers, and supplies custom and catalog biopharmaceutical affinity purification solutions to the biopharmaceutical industry. Through this acquisition, Repligen Corporation would be able to strengthen and extends its ligand discovery and development capabilities.

Geographical Expansions:

Aug-2022: Thermo Fisher Scientific, Inc. opened a new manufacturing site in Greater Nashville, United States. The facility allows Thermo Fisher Scientific to help meet fastly growing demand for the bioprocessing materials to deliver vaccines and breakthrough therapies for cancer and other diseases.

Sep-2021: Sartorius expanded its geographical footprint with the opening pf new plant in Ann Arbor, United States. Through this geographical expansion, Sartorius would offer advanced solutions to help customers develop drugs that prevent, cure and ends the progress of disease.

Scope of the Study

Market Segments covered in the Report:

By Application

• Bioprocessing/Biopharmaceuticals
• Pharmaceuticals Manufacturing
• Laboratory Use

• Membrane Filtration
• Tangential Flow Filtration (TFF)
• Others
• Depth Filtration
• Centrifugation
• Others

• Filters
• Membranes
• Cassettes
• Cartridges
• Manifold
• Syringes
• Others

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

• 3M Company
• Sartorius AG
• Repligen Corporation
• Merck Millipore (Merck Group)
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Meissner Filtration Products, Inc.
• Cellab CDMO
• Medela AG
• DrM, Dr. Mueller AG

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free